Most UAE heart content is about surgery. But the majority of cardiac patients never reach an operating theatre — they need diagnosis, an acute-event pathway, or ongoing management. Mediclinic City Hospital holds the UAE's first JCI-certified Acute Coronary Syndrome programme.
Severance in Seoul houses Korea's first national specialist cardiovascular hospital and treats over 50,000 international patients a year, with interpreters in English, Chinese, Japanese, Russian, Arabic and Mongolian. For a cardiac patient, the language infrastructure is not a footnote.
A bypass in Israel runs around $25,000 — against $9,000–22,000 in Turkey and less again in Georgia. Israel is the costly end of this series, so the case for it has to be something the cheaper destinations can't do at all. Cardiogenetics is that case.
A bypass in Mexico runs $15,000-22,000 against $80,000-150,000 uninsured in the US. Hospital Galenia in Cancún is the only hospital in Mexico accredited by both JCI and Accreditation Canada International — which is the whole point for a North American patient.
Coronary bypass surgery runs SGD 40,000-80,000 in Singapore's private hospitals. The same procedure at JCI-accredited Malaysian hospitals costs roughly RM 50,000-120,000 — a fraction of the price for the same accreditation standard.
Motol University Hospital runs the Czech Republic's nationwide Children's Heart Centre — around 500 congenital heart operations a year, including transplants. For paediatric cardiac cases, that's a different category from a general hospital.
For a cardiac condition, the wait itself carries risk. Madrid and Barcelona's JCI-accredited centres schedule bypass and valve surgery within 2-4 weeks — against 6-18 months on the NHS — at roughly 30-40% below UK and German pricing.
Georgia has four clinics listing cardiology, but only one — CMC Hospital Tbilisi — has a dedicated cardiac surgery department and ICU. For anything beyond a consultation, that distinction matters more than price.